Turku University Hospital
Turku, 20520, Finland
NCT Number: NCT02626871
The primary purpose of the FIN-bioAVR registry is to assess the incidence of AF, strokes and major bleeding events in patients undergoing aortic valve replacement. This retrospective multicenter registry will include 850 patients with aortic valve replacement using bioprosthesis.
Looking for future studies?
Notify Me18 year–99 year
All sexes
Observational
Turku, 20520, Finland
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 10 years
Time frame: 10 years
Time frame: 10 years
Time frame: 10 years
University of Turku
Other
Acronym: CAREAVR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05820295
Arrhythmias, Cardiac, Atrial Fibrillation
New York, United States
View Trial DetailsNCT03702582
Arrhythmias, Cardiac, Atrial Fibrillation
Boston, Massachusetts, United States
View Trial DetailsNCT05635864
Arrhythmias, Cardiac, Atrial Fibrillation
Hanover, Lower Saxony, Germany
View Trial DetailsNCT05809596
Arrhythmias, Cardiac, Atrial Fibrillation
Birmingham, Alabama, United States
View Trial Details